Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP736312.RAL35gV5u9XaJ53_J7qIHGsr_SKxrnbptRyyrFmzHRLKY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP736312.RAL35gV5u9XaJ53_J7qIHGsr_SKxrnbptRyyrFmzHRLKY130_assertion type Assertion NP736312.RAL35gV5u9XaJ53_J7qIHGsr_SKxrnbptRyyrFmzHRLKY130_head.
- NP736312.RAL35gV5u9XaJ53_J7qIHGsr_SKxrnbptRyyrFmzHRLKY130_assertion description "[However, A-T haplotype of G-6A and M235T interacting with homozygous ACE_II (beta=-1.07, P=0.006) and with ACE inhibitors (beta=-1.03, P=0.01) significantly decreased the risk of LEAD in white but not in black participants after adjustment for the selected CVD risk factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736312.RAL35gV5u9XaJ53_J7qIHGsr_SKxrnbptRyyrFmzHRLKY130_provenance.
- NP736312.RAL35gV5u9XaJ53_J7qIHGsr_SKxrnbptRyyrFmzHRLKY130_assertion evidence source_evidence_literature NP736312.RAL35gV5u9XaJ53_J7qIHGsr_SKxrnbptRyyrFmzHRLKY130_provenance.
- NP736312.RAL35gV5u9XaJ53_J7qIHGsr_SKxrnbptRyyrFmzHRLKY130_assertion SIO_000772 17429448 NP736312.RAL35gV5u9XaJ53_J7qIHGsr_SKxrnbptRyyrFmzHRLKY130_provenance.
- NP736312.RAL35gV5u9XaJ53_J7qIHGsr_SKxrnbptRyyrFmzHRLKY130_assertion wasDerivedFrom befree-20140225 NP736312.RAL35gV5u9XaJ53_J7qIHGsr_SKxrnbptRyyrFmzHRLKY130_provenance.
- NP736312.RAL35gV5u9XaJ53_J7qIHGsr_SKxrnbptRyyrFmzHRLKY130_assertion wasGeneratedBy ECO_0000203 NP736312.RAL35gV5u9XaJ53_J7qIHGsr_SKxrnbptRyyrFmzHRLKY130_provenance.